Author

Fangyuan Cao

Imperial College LondonORCID 0000-0003-0189-7764Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Molecular Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3

Frequent Co-Authors

Edward W. TateiD· 2 shared Anouk M. La RoseiD· 1 shared Bin LiuiD· 1 shared Chloe Huang· 1 shared Christopher W. am EndeiD· 1 shared Dafydd R. OweniD· 1 shared Dahye KangiD· 1 shared Daniel ConoleiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Edward W. TateORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular BiologyJournal of the American Chemical SocietyPeer-reviewedJun 10, 2025

Identification of actionable targeted protein degradation effector sites through Site-specific Ligand Incorporation-induced Proximity (SLIP)

Zhangping Xiao, Efthymios-Spyridon Gavriil, Fangyuan Cao…·Edward W. Tate

The paper introduces a chemical-genetic platform called SLIP to identify actionable sites on effector proteins for targeted protein degradation.

17 citationstop 3%

experimental assay

𝕏 PostBluesky

Systems BiologybioRxivPreprintSep 28, 2022

Electrophile scanning by chemical proteomics reveals a potent pan-active DUB probe for investigation of deubiquitinase activity in live cells

Daniel Conole, Fangyuan Cao, Christopher W. am Ende…·Edward W. Tate

The paper identifies a small molecule DUB probe, IMP-2373, that quantitatively engages multiple DUBs in live cells and demonstrates its use in studying DUB activity changes during MYC deregulation.

DOI 10.1101/2022.09.28.509970

experimental assay

𝕏 PostBluesky

GenomicsNucleic Acids ResearchPeer-reviewedNov 21, 2019

Inhibition of Histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing

Bin Liu, Siwei Chen, Anouk M. La Rose…·Hidde J. Haisma

The paper shows that inhibiting HDAC1 and HDAC2 improves CRISPR/Cas9 gene editing efficiency by opening chromatin and enhancing Cas9 access.

371 citationstop 1%

experimental assay

𝕏 PostBluesky